CA1271716A - Technique for visualization of genetic material - Google Patents
Technique for visualization of genetic materialInfo
- Publication number
- CA1271716A CA1271716A CA000458836A CA458836A CA1271716A CA 1271716 A CA1271716 A CA 1271716A CA 000458836 A CA000458836 A CA 000458836A CA 458836 A CA458836 A CA 458836A CA 1271716 A CA1271716 A CA 1271716A
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- stain
- dna
- fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 71
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 20
- 238000012800 visualization Methods 0.000 title abstract description 13
- 210000004027 cell Anatomy 0.000 claims abstract description 102
- 235000013601 eggs Nutrition 0.000 claims abstract description 28
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 13
- 210000002459 blastocyst Anatomy 0.000 claims abstract description 12
- 210000004602 germ cell Anatomy 0.000 claims abstract description 7
- 239000002609 medium Substances 0.000 claims description 26
- 238000010186 staining Methods 0.000 claims description 17
- 241000283690 Bos taurus Species 0.000 claims description 15
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical class C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 claims description 12
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 8
- 210000004962 mammalian cell Anatomy 0.000 claims description 8
- 239000000975 dye Substances 0.000 claims description 5
- 230000013020 embryo development Effects 0.000 claims description 4
- DOETVZCFKJCYJV-UHFFFAOYSA-N 6-(4,5-dihydro-1h-imidazol-2-yl)-2-[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]-1h-indole Chemical compound N1CCN=C1C1=CC=C(C=2NC3=CC(=CC=C3C=2)C=2NCCN=2)C=C1 DOETVZCFKJCYJV-UHFFFAOYSA-N 0.000 claims description 3
- 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 claims description 3
- 230000004899 motility Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 2
- VIBDVOOELVZGDU-UHFFFAOYSA-N 4-(1h-indol-2-yl)benzene-1,3-dicarboximidamide Chemical compound NC(=N)C1=CC(C(=N)N)=CC=C1C1=CC2=CC=CC=C2N1 VIBDVOOELVZGDU-UHFFFAOYSA-N 0.000 claims 5
- 230000000052 comparative effect Effects 0.000 claims 1
- 238000010353 genetic engineering Methods 0.000 claims 1
- 238000005286 illumination Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 210000002257 embryonic structure Anatomy 0.000 description 54
- 239000011550 stock solution Substances 0.000 description 24
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- 210000004940 nucleus Anatomy 0.000 description 18
- 210000000287 oocyte Anatomy 0.000 description 18
- 210000001161 mammalian embryo Anatomy 0.000 description 15
- 210000004508 polar body Anatomy 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 12
- 229940098773 bovine serum albumin Drugs 0.000 description 11
- 230000004720 fertilization Effects 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000010867 Hoechst staining Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 210000003101 oviduct Anatomy 0.000 description 6
- 108010077544 Chromatin Proteins 0.000 description 5
- 210000003483 chromatin Anatomy 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000035800 maturation Effects 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000472 morula Anatomy 0.000 description 4
- 239000011824 nuclear material Substances 0.000 description 4
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229960000448 lactic acid Drugs 0.000 description 3
- 230000031864 metaphase Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 239000004218 Orcein Substances 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000007630 basic procedure Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 210000001771 cumulus cell Anatomy 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QFIIYGZAUXVPSZ-UHFFFAOYSA-N 8-(2,4-dihydroxy-6-methylanilino)-2-(2,4-dihydroxy-6-methylphenyl)imino-7-hydroxy-1,9-dimethyldibenzofuran-3-one Chemical compound CC1=CC(=CC(=C1NC2=C(C3=C(C=C2O)OC4=CC(=O)C(=NC5=C(C=C(C=C5C)O)O)C(=C43)C)C)O)O QFIIYGZAUXVPSZ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- SMNPLAKEGAEPJD-UHFFFAOYSA-N chembl34922 Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(NC(=N2)C=3C=C4N=C(NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 SMNPLAKEGAEPJD-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 231100000722 genetic damage Toxicity 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000003783 haploid cell Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000019248 orcein Nutrition 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
ABSTRACT
A technique for the visualization of mammalian genetic material in living germ cells, one-cell fertilized eggs and pre-implantation embryo cells is disclosed. The cells are incubated with a fluorescent dye and the stained DNA
is visualized by exposing the cell to ultraviolet light.
A technique for the visualization of mammalian genetic material in living germ cells, one-cell fertilized eggs and pre-implantation embryo cells is disclosed. The cells are incubated with a fluorescent dye and the stained DNA
is visualized by exposing the cell to ultraviolet light.
Description
1~7~71~i BACKGROUND OF THE INVENTION
This invention relates generally to staining techniques for biological genetic material. More specifically, the method of this invention provides a unique means of visualizing (1) the pronuclei of living pronuclear cells, including ova and one-cell fertilized eggs (2) the condensed DNA in the heads of spermatozoa, and (3) the nuclei of pre-implantation embryos.
Visualization of the genetic material in these types of living cells is critical for further research and development of ln vitro fertilization and maturation, gene and nuclear transfer capabilities and subsequent cloning of domestic animal embryos. Heretofore, pronuclei and sperm DNA have not been seen in living, viable mammalian cells, except for rodents and humans where the cytoplasm of these cells is clear. In more mature embryos, the area of the nuclei may be somewhat discernable, but tne cells' smaller size makes it impossible to visualize individual nuclei.
Advanced genetic improvement and selection techniques continue to be sought in the field of animal husbandry.
With specific reference to dairy cattle, for example, significant increases in milk production have been seen with the wide scale use of genetically superior sires and artiEicial insemination. Dairy cows today produce nearly twice as much milk as they did 30 years ago. Further genetic improvement can be accomplished by the multiplication of superior or genetically manipulated embryos by cloning. Embryos may be cloned by (1) replacement of pronuclei or nuclei in a fertilized egg cell with donor pronuclei or with nuclei from an early multicellular embryo or (2) transfer of a valuable gene into the pror.ucleus or nucleus.
1~7~
Gene transfer requires the pronucleus or nucleus of the recipient cell to be visible so that DNA fragments containing the desired gene sequences can be transferred by micromanipulation directly into one of the pronuclei or the nucleus. Nuclear transfer, on the other hand, requires the nucleus or the male and female pronuclei to be visible so that they can be removed from the fertilized cell in exchange for a nucleus from the desired clonal line. Techniques such as these involving the manipulation of genetic material were developed in research with murine embryos in which the cytoplasm of the pronuclear and embryo cell is clear, permitting visualization of the nuclear material in living cells by light microscopy.
The situation in bovine and porcine gametes and pre-implantation embryo cells is quite different. The cytoplasm of these cells is dense and granular and contains thiclc lipid droplets. The genetic material is obscured and cannot be visualized by light microscopy.
Conventional nuclear stains are not vital stains; that is, they require that the cells be fixed and cleared prior to staining. Bovine and porcine gametes and pre-implantation embryo cells therefore normally have been examined in fixed, cleared and nonliving specimens.
As discussed above, genetic improvement techniques such as gene and nuclear transfer require the selective staining of the nuclear or pronuclear material in living pronuclear or embryo cells. These techniques, together with a host of laboratory research tasks, are made possible by the technique of this invention which provides a visualization method with the necessary selectivity and which can be used with living cells.
~7171~j ~UMMARY OF THE INVENTION
The technique described herein enables the male and female pronuclei to be visualized in living mammalian cells, even in those species in which the density of the cell cytoplasm normally obscures the pronuclei.
Visualization of pronuclei in living cells has not previously been reported, except rodent and human cells.
The technique also provides a means for visualization of the nuclear material of multi-cell embryos, making it possible to count the number of cells present in a developing embryo after each cleavage as well as manipulate the genetic material for gene and nuclear transfer.
Visualization is accomplished by exposure of the living cells to a stain or dye which is specific for double stranded DNA but which does not preclude the continued viability of the cell. Flucrescent stains, such as DAPI or the bis-benzimidazole compounds, are used. The stain is added to the culture medium containing gametes, one-cell fertilized eggs or multi-cell embryos. After incubation, which can be for as short a time as several minutes, the genetic material can be visualized by exposure to ultraviolet light. The pronuclear or nuclear structures appear as stained areas within the cytoplasm.
The intensity varies from very faint to bright fluorescing.
An overall object of this invention is to enable and facilitate laboratory research tasks such as gene and nuclear transfer techniques, and studies of the patterns and progress of ln vitro maturation of oocytes, and ln vitro fertilization and embryo culture.
7~
One of the principal objects of this invention is to provide a technique for the visualization of the pronuclei of living mammalian pronuclear cells.
It is a more specific object to permit visualization of the male and female DNA or pronuclei of living mammalian gametes and one-cell fertilized eggs, bovine and porcine in particular.
It is a further object to provide a like technique which will allow for the visulization of nuclear material of multi-cell embryos.
A related object i5 to provide a means for the differential staining of the genetic material and the cytoplasmic contents.
Still another object is to provide a means of staining the genetic material in living germ and embryo cells in a manner which is likely to allow maintenance of the health and viability of the cells.
In addition, it is desired to provide a stain whlch will not cause excessive damage or alteration to the genetic material.
DETAILED DESCRIPTI~N OF THE INVENTION
The method of this invention provides a technique for the differential staining of certain genetic material which never before has been visible in living cells. The fluorescent stains used in this method selectively stain the genetic material o~ the cells, without requiriny the cells to be ~ixed and cleared. The selectivity of this staining technique provides a powerful research tool which will facilitate further investigation of fertilization, embryological development and gene and nuclear transfer in domestic animal embryos.
1~7~l7~
The stains of this method can be used to selectively stain the genetic material of any species. However, the technique finds its highest value with those species in which the cytoplasmic materials (e.g., lipids) obscure the pronuclear or nuclear material in the living ~tate.
Examples of considerable interest and importance to the animal breeding industry are cattle and swine.
Application of the technique to other research or domestic animals is contemplated as well.
It has been found that certain fluorescent stains used according to this method will achieve the dual objectives of selectivity of staining and continued viability of the cells. Fluorescent stains which are so-called "vital stains," that is, which do not require the cells to be fixed and cleared and which do not interfere with the continued development of the cell, may be useful in this procedure. In addition, the stain should be of the type which is incorporated into the cell and which is taken up by the double stranded DNA in living germ or embryo cells.
Stains belonging to the class of bis-benzimidazole fluorescent dyes have been found to be particularly useful in this method. This class of compounds has the basic structure:
C~ ,~., ~,r~ Lt;~
A series of stains in this class is available from Hoechst AG, Frankfurt, Germany. Compounds ln this series include:
Hoechst No. R R' 32020 CH3-N~ -Cl 32021 CH3-N~ -OCH3 33258 C~3-N~ -OH
33342 CH3-N~ C2H5 33662 C2H5 N` -OCH3 34580 CH3-N~ N~CU3 10 38312 H-C~ -Cl 38317 H-C~ -NH2 Studies by S. A. Latt et al., "Spectral Studies on 33258 Hoechst and Related Bisbenzimidazole Dyes Useful for Fluorescent Detestion of Deoxyribonucleic Acld Synthesis,"
Journal of Histochemistry and Cytochemistry, Vol. 23, pp.
24-33 (1976), demonstrate the similarity of the series of compounds listed above and disclose that these compounds are useful in the detection of DNA synthesis in somatic cells.
The ExampLes that follow demonstrate that Hoechst stain Nos. 33258 and 33342 are useful in the technique disclosed herein. The chemical name of Hoechst stain No.
33258 is 2-[2-(4-hydroxyphenyl)-6-benzimidazoyl]-6-(1-methyl-4-piperazyl)-benzimadazole. The chemical name 25 of Hoechst stain No. 33342 is 2-[2-(4-ethoxy phenyl)-6-benzimidazoyl]-6-(1-ethyl-4-piperazyl)-benzimadazole. It is expected that the related bis-benzimidazole compounds will all be useful for the 7~i selective visualization of genetic material in living germ or embryo cells. Of the two compounds actually tested, Hoechst stain No. 33342 significantly outperformed Hoechst No. 333258 and therefore is the preferred reagent~ It has been noted, however, that the cells of the various species will take up different stains with differing efficiency.
For example, Hoechst No. 33258 was taken up rapidly by mouse embryos, but quite slowly by bovine embryos.
Other fluorescent stains meeting the requirements described above, that is, DNA-binding fluorochromes which may be used as vital stains, are expected to be useful with this method as well. Examples include, but are not limited to DAPI (4'6-diamidino-2-phenylindole), and DIPI
(a compound similar to DAPI).
The method by which the genetic material in gametes or embryo cells is stained essentially entails exposure of the cells to a suitable fluorescent stain, incubation and exposure to ultraviolet light. The stain dosage and the incubation period can be varied, depending on the stain used and the purpose for which visualization is desired.
No false positives have been found using this staining technique; that is, the procedure has not been found to significantly stain materials other than nuclear or pronuclear DNA. It has been noted, however, that o~erstained cells will exhibit some background staining.
The technique has been found to result in some false negatives; that is, some cells failed to fluoresce which were found by other methods to contain nuclei or pronuclei. It is not considered that this will hinder or ~.~71~
compromise the usefulness of the technique in either a laboratory or commercial setting.
Egg cells (oocytes), one-cell fertilized eggs or pre-implantation embryos are obtained from mature female animals by conventional means which will preserve the health of the cells. Sperm cells (spermatozoa) are obtained from the ejaculate of mature male animals or from excised testes, epididymis or part of the male duct system. Germ cells or gametes (oocytes and spermatozoa) are haploid cells which will unite to form a fertilized egg. The fertilized egg (containing the male and female pronuclei) then undergoes syngamy (the union of the male and female pronuclei to produce a zygote nucleus), followed by a series of cell divisions. As the embryo undergoes a series of mitotic divisions, it develops through the morula stage to the blastocyst stage, when tissue differentiation and specialization occur.
Ultimately, this leads to formation of the fetus and placenta, which become implanted on the uterine wall.
It is the embryo in the pre-implantation stages, as well as the germ cells and one-cell fertilized eggs, which are the primary focus of this invention. These very early cells are the subjects of intensive research efforts. The gene and nuclear transfer techniques described above utilize fertilized egg cells and early embryo cells. The technique has proven useful in other embryological research as well. For example, it enables researchers to study the development of ln vitro fertilized eggs, e.g., the symmetry of nuclear and cytoplasmic division, the appearance of a single nucleus in each blastomere, the number of cells in the embryo after each division, etc.
L71~
In addition, it is useful for studying the health and motility of spermatozoa.
The germ or embryo cells preferably are placed in culture medium appropriate for maintaining the health and viability of the cells. The preferred culture medium for a given application, e.g., for cells of a particular species and at a particular developmental stage, will be known to one skilled in the art. Several suitable media are given in the Examples. Sperm may be examined in semen, in semen with conventional extenders such as egg yolk or milk extender, or in culture medium.
The stain preferably is used in solution. This allows for more precise regulation of the dosage, as well as allowing very dilute strengths of the stain to be used.
It is believed that lower dosages may have less tendency to cause genetic damage to the cell.
A stock solution of the stain may be prepared using any suitabl~ solvent; that is, any solvent for the stain which will not adversely affect the living cells.
Examples include, but are not limited to Dulbecco's Phosphate Buffered Saline (DPBS), TALP, Whittens or Eagles media, or any other media or solvent compatable with the continued viability of the cells. The stain stock solution preferably should be stored at refrigerated temperatures, preferably about 0C to 4C, in order to reduce the possibility of contamination. However, it should be noted that freezing generally will not be desirable as it causes the salts to precipitate out of the solution.
The strength of the stain stock solution may be varied, as desired. A stronger solution will stain genetic material in a shorter period, whereas a weaker solution will require a longer incubation period before the material fluoresces. In addition, the stain uptake rate varies with the species, with bovine and porcine cells requiring a much longer incubation period than murine cells. As noted above, lower dosages of the stain may be preferred to maintain the health and viàbility of the cells.
For example, using a stock solution o 20 ~g stain per ml DPBS, as little as 1 ~1 in 49 ~1 of media (50 ~1 total volume) containing mouse one-cell embryos resulted in distinct fluorescence of pronuclei and at least one polar body within 15 minutes. Using bovine one-cell embryos and 20 ~g/ml stain stock solution at a dosage of 2 ~1 in 48 ~1 of culture media containing embryos, polar bodies fluoresced within 30 minutes, while the pronuclei were not visible for 1 to 2 hours. As can be seen with reference to the Examples, the dose and incubation period may be varied as desired for various experimental or other purposes.
The stained structures may be visualized microscopically by exposure to ultraviolet light. Light at an excitation wavelength of about 350 nm and emission about 460 nm has been found to be suitable. Nuclei and pronuclei appear as stained blue areas within the cell cytoplasm. Sperm have no discrete pronuclei; the DNA is condensed and packed into the head of the sperm where it may be visualized by this method. Where pronuclei are referred to, it is meant to include the DNA of sperm, unless otherwise specified. Depending on the amount of stain taken up by the DNA, which is a function of dose and time, the intensity will vary from very faintly to brightly fluorescing.
~7~7~
The following Examples are given for illustrative purposes only and are not meant to limit the invention described herein except as defined by the appended claims.
The stock solutions and culture media used in the Examples were prepared as indicated below.
Preparation of Dulbecco's Phosphate Buffered Saline (DPBS) Dulbecco's Phosphate Buffered Saline (DPBS) was prepared as follows:
Solution #1 8.00 gm NaCl 0.20 gm KCl 1.15 gm Na2HPO4 0.20 gm KH PO
800.00 ml de21on4lzed distilled water Solution #2 0.1 gm CaC12 100.0 ml deionized distilled water Solution #3 0.1 gm MgC12 100.0 ml deionized distilled water Each solution was steam autoclaved separately at 120-125C
for 20 minutes and then cooled. The three solutions were mixed in a one liter volumetric flask, and the total volume adjusted to one liter with autoclaved deicnized distilled water. The DPBS stock solution was refrigerated at about 4C.
When DPBS was used to wash cells, 5 mg (0.1 ml) gentamycin sulfate stock solution first was added to 100 ml DPBS. The gentamycin stock solution was 50 mg gentamycinS04 per ml NaCl.
.S
Preparation of Stain Stock Solutions Stain stock solutions using Hoechst No. 33342 were prepared in the following concentrations:
lO ~g/ml DPBS
20 ~g/ml DPBS
60 ~g/ml DPBS
Stain stock solutions using Hoescht No. 33258 was prepared in the following concentrations:
10 ~g/ml DPBS
20 ~g/ml DPBS
The stain stock solutions were stored at 4C.
Preparation of TALP (Ty~ode-Albumin-Lactate-Pyruvate) Medium Preparation of stock solutions for use in making up TAI.P medium was as follows:
,.
Ingredient Quantity In:
NaCl 9.210 gm 1.0 1 H2O
KCl 1.237 gm 100 ml H2O
CaCl2(2H2O) 1.332 gm 100 ml H2O
MgC12(6H2O) 2.436 gm 100 ml H2O
NaHCO3 1.403 gm + 1 mg 100 ml H2O
phenol red Glucose 5.310 gm 100 ml H O
25 Na Lactate 1.0 ml DL-Lactic Acid* 2 NaH2PO4(~2o) 28.0 mg **
71~
*DL-Lactic acid, sodium salt as 60% syrup (Sigma Chemical Co.) The 1.0 ml lactic acid syrup was rinsed into the 35 ml H2O until it was in solution. One drop phenol red was added. The pH was adjusted to approximately 7.4 with NaOH (overshoots may be corrected by adding a very small drop of lactate).
**The 28 mg NaH2PO4(H2O) was mixed with 10 ml of the Glucose stock solution as prepared above.
The ingredients for each stock solution were mixed, Millipore filtered (0.22 ~ pore size) into sterile bottles, and refrigerated at about 4C.
The TALP medium was made up as needed by mixing the following quantities of stock solutions:
Stock Conc. in StockConc. Medium Quantity NaCl157.0 mM 114.00 mMto 100 ml KCl 166.0 mM 3.16 mM 1.90 ml CaC12(2H2O)120.0 mM 2.00 mM 1.70 ml MgCl2(6H2O~120.0 mM 0.50 mM 0.41 ml 20 NaHCO3167.0 mM 25.00 mM 15.00 ml NaH2PO4(H2O) 20.5 mM0.35 mM) together 1.70 ml Glucose295.0 mM 5.00 mM) Na Lactate150.0 mM 10.00 mM 6.70 ml The indicated quantities were mixed together wlth sufficient NaC1 to bring the final volume to 100 ml and 6.5 mg penicillin (100 i.u./ml) and 1.0 mg phenol red were added. The resulting mixture was Millipore filtered (0.22 ~ pore size) into a sterile bottle.
On the day of use, the TALP medium was supplemented as follows, depending on the desired use:
1~7~
1. Fertilization Medium - 6 mg Bovine Serum Albumin (BSA) (fatty acid free) and 10 ~1 Na pyruvate stock per ml TALP was added and Millipore filtered. (BSA from Sigma Chemical Co.) or
This invention relates generally to staining techniques for biological genetic material. More specifically, the method of this invention provides a unique means of visualizing (1) the pronuclei of living pronuclear cells, including ova and one-cell fertilized eggs (2) the condensed DNA in the heads of spermatozoa, and (3) the nuclei of pre-implantation embryos.
Visualization of the genetic material in these types of living cells is critical for further research and development of ln vitro fertilization and maturation, gene and nuclear transfer capabilities and subsequent cloning of domestic animal embryos. Heretofore, pronuclei and sperm DNA have not been seen in living, viable mammalian cells, except for rodents and humans where the cytoplasm of these cells is clear. In more mature embryos, the area of the nuclei may be somewhat discernable, but tne cells' smaller size makes it impossible to visualize individual nuclei.
Advanced genetic improvement and selection techniques continue to be sought in the field of animal husbandry.
With specific reference to dairy cattle, for example, significant increases in milk production have been seen with the wide scale use of genetically superior sires and artiEicial insemination. Dairy cows today produce nearly twice as much milk as they did 30 years ago. Further genetic improvement can be accomplished by the multiplication of superior or genetically manipulated embryos by cloning. Embryos may be cloned by (1) replacement of pronuclei or nuclei in a fertilized egg cell with donor pronuclei or with nuclei from an early multicellular embryo or (2) transfer of a valuable gene into the pror.ucleus or nucleus.
1~7~
Gene transfer requires the pronucleus or nucleus of the recipient cell to be visible so that DNA fragments containing the desired gene sequences can be transferred by micromanipulation directly into one of the pronuclei or the nucleus. Nuclear transfer, on the other hand, requires the nucleus or the male and female pronuclei to be visible so that they can be removed from the fertilized cell in exchange for a nucleus from the desired clonal line. Techniques such as these involving the manipulation of genetic material were developed in research with murine embryos in which the cytoplasm of the pronuclear and embryo cell is clear, permitting visualization of the nuclear material in living cells by light microscopy.
The situation in bovine and porcine gametes and pre-implantation embryo cells is quite different. The cytoplasm of these cells is dense and granular and contains thiclc lipid droplets. The genetic material is obscured and cannot be visualized by light microscopy.
Conventional nuclear stains are not vital stains; that is, they require that the cells be fixed and cleared prior to staining. Bovine and porcine gametes and pre-implantation embryo cells therefore normally have been examined in fixed, cleared and nonliving specimens.
As discussed above, genetic improvement techniques such as gene and nuclear transfer require the selective staining of the nuclear or pronuclear material in living pronuclear or embryo cells. These techniques, together with a host of laboratory research tasks, are made possible by the technique of this invention which provides a visualization method with the necessary selectivity and which can be used with living cells.
~7171~j ~UMMARY OF THE INVENTION
The technique described herein enables the male and female pronuclei to be visualized in living mammalian cells, even in those species in which the density of the cell cytoplasm normally obscures the pronuclei.
Visualization of pronuclei in living cells has not previously been reported, except rodent and human cells.
The technique also provides a means for visualization of the nuclear material of multi-cell embryos, making it possible to count the number of cells present in a developing embryo after each cleavage as well as manipulate the genetic material for gene and nuclear transfer.
Visualization is accomplished by exposure of the living cells to a stain or dye which is specific for double stranded DNA but which does not preclude the continued viability of the cell. Flucrescent stains, such as DAPI or the bis-benzimidazole compounds, are used. The stain is added to the culture medium containing gametes, one-cell fertilized eggs or multi-cell embryos. After incubation, which can be for as short a time as several minutes, the genetic material can be visualized by exposure to ultraviolet light. The pronuclear or nuclear structures appear as stained areas within the cytoplasm.
The intensity varies from very faint to bright fluorescing.
An overall object of this invention is to enable and facilitate laboratory research tasks such as gene and nuclear transfer techniques, and studies of the patterns and progress of ln vitro maturation of oocytes, and ln vitro fertilization and embryo culture.
7~
One of the principal objects of this invention is to provide a technique for the visualization of the pronuclei of living mammalian pronuclear cells.
It is a more specific object to permit visualization of the male and female DNA or pronuclei of living mammalian gametes and one-cell fertilized eggs, bovine and porcine in particular.
It is a further object to provide a like technique which will allow for the visulization of nuclear material of multi-cell embryos.
A related object i5 to provide a means for the differential staining of the genetic material and the cytoplasmic contents.
Still another object is to provide a means of staining the genetic material in living germ and embryo cells in a manner which is likely to allow maintenance of the health and viability of the cells.
In addition, it is desired to provide a stain whlch will not cause excessive damage or alteration to the genetic material.
DETAILED DESCRIPTI~N OF THE INVENTION
The method of this invention provides a technique for the differential staining of certain genetic material which never before has been visible in living cells. The fluorescent stains used in this method selectively stain the genetic material o~ the cells, without requiriny the cells to be ~ixed and cleared. The selectivity of this staining technique provides a powerful research tool which will facilitate further investigation of fertilization, embryological development and gene and nuclear transfer in domestic animal embryos.
1~7~l7~
The stains of this method can be used to selectively stain the genetic material of any species. However, the technique finds its highest value with those species in which the cytoplasmic materials (e.g., lipids) obscure the pronuclear or nuclear material in the living ~tate.
Examples of considerable interest and importance to the animal breeding industry are cattle and swine.
Application of the technique to other research or domestic animals is contemplated as well.
It has been found that certain fluorescent stains used according to this method will achieve the dual objectives of selectivity of staining and continued viability of the cells. Fluorescent stains which are so-called "vital stains," that is, which do not require the cells to be fixed and cleared and which do not interfere with the continued development of the cell, may be useful in this procedure. In addition, the stain should be of the type which is incorporated into the cell and which is taken up by the double stranded DNA in living germ or embryo cells.
Stains belonging to the class of bis-benzimidazole fluorescent dyes have been found to be particularly useful in this method. This class of compounds has the basic structure:
C~ ,~., ~,r~ Lt;~
A series of stains in this class is available from Hoechst AG, Frankfurt, Germany. Compounds ln this series include:
Hoechst No. R R' 32020 CH3-N~ -Cl 32021 CH3-N~ -OCH3 33258 C~3-N~ -OH
33342 CH3-N~ C2H5 33662 C2H5 N` -OCH3 34580 CH3-N~ N~CU3 10 38312 H-C~ -Cl 38317 H-C~ -NH2 Studies by S. A. Latt et al., "Spectral Studies on 33258 Hoechst and Related Bisbenzimidazole Dyes Useful for Fluorescent Detestion of Deoxyribonucleic Acld Synthesis,"
Journal of Histochemistry and Cytochemistry, Vol. 23, pp.
24-33 (1976), demonstrate the similarity of the series of compounds listed above and disclose that these compounds are useful in the detection of DNA synthesis in somatic cells.
The ExampLes that follow demonstrate that Hoechst stain Nos. 33258 and 33342 are useful in the technique disclosed herein. The chemical name of Hoechst stain No.
33258 is 2-[2-(4-hydroxyphenyl)-6-benzimidazoyl]-6-(1-methyl-4-piperazyl)-benzimadazole. The chemical name 25 of Hoechst stain No. 33342 is 2-[2-(4-ethoxy phenyl)-6-benzimidazoyl]-6-(1-ethyl-4-piperazyl)-benzimadazole. It is expected that the related bis-benzimidazole compounds will all be useful for the 7~i selective visualization of genetic material in living germ or embryo cells. Of the two compounds actually tested, Hoechst stain No. 33342 significantly outperformed Hoechst No. 333258 and therefore is the preferred reagent~ It has been noted, however, that the cells of the various species will take up different stains with differing efficiency.
For example, Hoechst No. 33258 was taken up rapidly by mouse embryos, but quite slowly by bovine embryos.
Other fluorescent stains meeting the requirements described above, that is, DNA-binding fluorochromes which may be used as vital stains, are expected to be useful with this method as well. Examples include, but are not limited to DAPI (4'6-diamidino-2-phenylindole), and DIPI
(a compound similar to DAPI).
The method by which the genetic material in gametes or embryo cells is stained essentially entails exposure of the cells to a suitable fluorescent stain, incubation and exposure to ultraviolet light. The stain dosage and the incubation period can be varied, depending on the stain used and the purpose for which visualization is desired.
No false positives have been found using this staining technique; that is, the procedure has not been found to significantly stain materials other than nuclear or pronuclear DNA. It has been noted, however, that o~erstained cells will exhibit some background staining.
The technique has been found to result in some false negatives; that is, some cells failed to fluoresce which were found by other methods to contain nuclei or pronuclei. It is not considered that this will hinder or ~.~71~
compromise the usefulness of the technique in either a laboratory or commercial setting.
Egg cells (oocytes), one-cell fertilized eggs or pre-implantation embryos are obtained from mature female animals by conventional means which will preserve the health of the cells. Sperm cells (spermatozoa) are obtained from the ejaculate of mature male animals or from excised testes, epididymis or part of the male duct system. Germ cells or gametes (oocytes and spermatozoa) are haploid cells which will unite to form a fertilized egg. The fertilized egg (containing the male and female pronuclei) then undergoes syngamy (the union of the male and female pronuclei to produce a zygote nucleus), followed by a series of cell divisions. As the embryo undergoes a series of mitotic divisions, it develops through the morula stage to the blastocyst stage, when tissue differentiation and specialization occur.
Ultimately, this leads to formation of the fetus and placenta, which become implanted on the uterine wall.
It is the embryo in the pre-implantation stages, as well as the germ cells and one-cell fertilized eggs, which are the primary focus of this invention. These very early cells are the subjects of intensive research efforts. The gene and nuclear transfer techniques described above utilize fertilized egg cells and early embryo cells. The technique has proven useful in other embryological research as well. For example, it enables researchers to study the development of ln vitro fertilized eggs, e.g., the symmetry of nuclear and cytoplasmic division, the appearance of a single nucleus in each blastomere, the number of cells in the embryo after each division, etc.
L71~
In addition, it is useful for studying the health and motility of spermatozoa.
The germ or embryo cells preferably are placed in culture medium appropriate for maintaining the health and viability of the cells. The preferred culture medium for a given application, e.g., for cells of a particular species and at a particular developmental stage, will be known to one skilled in the art. Several suitable media are given in the Examples. Sperm may be examined in semen, in semen with conventional extenders such as egg yolk or milk extender, or in culture medium.
The stain preferably is used in solution. This allows for more precise regulation of the dosage, as well as allowing very dilute strengths of the stain to be used.
It is believed that lower dosages may have less tendency to cause genetic damage to the cell.
A stock solution of the stain may be prepared using any suitabl~ solvent; that is, any solvent for the stain which will not adversely affect the living cells.
Examples include, but are not limited to Dulbecco's Phosphate Buffered Saline (DPBS), TALP, Whittens or Eagles media, or any other media or solvent compatable with the continued viability of the cells. The stain stock solution preferably should be stored at refrigerated temperatures, preferably about 0C to 4C, in order to reduce the possibility of contamination. However, it should be noted that freezing generally will not be desirable as it causes the salts to precipitate out of the solution.
The strength of the stain stock solution may be varied, as desired. A stronger solution will stain genetic material in a shorter period, whereas a weaker solution will require a longer incubation period before the material fluoresces. In addition, the stain uptake rate varies with the species, with bovine and porcine cells requiring a much longer incubation period than murine cells. As noted above, lower dosages of the stain may be preferred to maintain the health and viàbility of the cells.
For example, using a stock solution o 20 ~g stain per ml DPBS, as little as 1 ~1 in 49 ~1 of media (50 ~1 total volume) containing mouse one-cell embryos resulted in distinct fluorescence of pronuclei and at least one polar body within 15 minutes. Using bovine one-cell embryos and 20 ~g/ml stain stock solution at a dosage of 2 ~1 in 48 ~1 of culture media containing embryos, polar bodies fluoresced within 30 minutes, while the pronuclei were not visible for 1 to 2 hours. As can be seen with reference to the Examples, the dose and incubation period may be varied as desired for various experimental or other purposes.
The stained structures may be visualized microscopically by exposure to ultraviolet light. Light at an excitation wavelength of about 350 nm and emission about 460 nm has been found to be suitable. Nuclei and pronuclei appear as stained blue areas within the cell cytoplasm. Sperm have no discrete pronuclei; the DNA is condensed and packed into the head of the sperm where it may be visualized by this method. Where pronuclei are referred to, it is meant to include the DNA of sperm, unless otherwise specified. Depending on the amount of stain taken up by the DNA, which is a function of dose and time, the intensity will vary from very faintly to brightly fluorescing.
~7~7~
The following Examples are given for illustrative purposes only and are not meant to limit the invention described herein except as defined by the appended claims.
The stock solutions and culture media used in the Examples were prepared as indicated below.
Preparation of Dulbecco's Phosphate Buffered Saline (DPBS) Dulbecco's Phosphate Buffered Saline (DPBS) was prepared as follows:
Solution #1 8.00 gm NaCl 0.20 gm KCl 1.15 gm Na2HPO4 0.20 gm KH PO
800.00 ml de21on4lzed distilled water Solution #2 0.1 gm CaC12 100.0 ml deionized distilled water Solution #3 0.1 gm MgC12 100.0 ml deionized distilled water Each solution was steam autoclaved separately at 120-125C
for 20 minutes and then cooled. The three solutions were mixed in a one liter volumetric flask, and the total volume adjusted to one liter with autoclaved deicnized distilled water. The DPBS stock solution was refrigerated at about 4C.
When DPBS was used to wash cells, 5 mg (0.1 ml) gentamycin sulfate stock solution first was added to 100 ml DPBS. The gentamycin stock solution was 50 mg gentamycinS04 per ml NaCl.
.S
Preparation of Stain Stock Solutions Stain stock solutions using Hoechst No. 33342 were prepared in the following concentrations:
lO ~g/ml DPBS
20 ~g/ml DPBS
60 ~g/ml DPBS
Stain stock solutions using Hoescht No. 33258 was prepared in the following concentrations:
10 ~g/ml DPBS
20 ~g/ml DPBS
The stain stock solutions were stored at 4C.
Preparation of TALP (Ty~ode-Albumin-Lactate-Pyruvate) Medium Preparation of stock solutions for use in making up TAI.P medium was as follows:
,.
Ingredient Quantity In:
NaCl 9.210 gm 1.0 1 H2O
KCl 1.237 gm 100 ml H2O
CaCl2(2H2O) 1.332 gm 100 ml H2O
MgC12(6H2O) 2.436 gm 100 ml H2O
NaHCO3 1.403 gm + 1 mg 100 ml H2O
phenol red Glucose 5.310 gm 100 ml H O
25 Na Lactate 1.0 ml DL-Lactic Acid* 2 NaH2PO4(~2o) 28.0 mg **
71~
*DL-Lactic acid, sodium salt as 60% syrup (Sigma Chemical Co.) The 1.0 ml lactic acid syrup was rinsed into the 35 ml H2O until it was in solution. One drop phenol red was added. The pH was adjusted to approximately 7.4 with NaOH (overshoots may be corrected by adding a very small drop of lactate).
**The 28 mg NaH2PO4(H2O) was mixed with 10 ml of the Glucose stock solution as prepared above.
The ingredients for each stock solution were mixed, Millipore filtered (0.22 ~ pore size) into sterile bottles, and refrigerated at about 4C.
The TALP medium was made up as needed by mixing the following quantities of stock solutions:
Stock Conc. in StockConc. Medium Quantity NaCl157.0 mM 114.00 mMto 100 ml KCl 166.0 mM 3.16 mM 1.90 ml CaC12(2H2O)120.0 mM 2.00 mM 1.70 ml MgCl2(6H2O~120.0 mM 0.50 mM 0.41 ml 20 NaHCO3167.0 mM 25.00 mM 15.00 ml NaH2PO4(H2O) 20.5 mM0.35 mM) together 1.70 ml Glucose295.0 mM 5.00 mM) Na Lactate150.0 mM 10.00 mM 6.70 ml The indicated quantities were mixed together wlth sufficient NaC1 to bring the final volume to 100 ml and 6.5 mg penicillin (100 i.u./ml) and 1.0 mg phenol red were added. The resulting mixture was Millipore filtered (0.22 ~ pore size) into a sterile bottle.
On the day of use, the TALP medium was supplemented as follows, depending on the desired use:
1~7~
1. Fertilization Medium - 6 mg Bovine Serum Albumin (BSA) (fatty acid free) and 10 ~1 Na pyruvate stock per ml TALP was added and Millipore filtered. (BSA from Sigma Chemical Co.) or
2. Maturation Medium - to 4.5 ml TALP, 500 ~1 fetal bovine serum (10%), 50 ~1 Na pyruvate stock and l0 mgFSH/ml TALP were added and Millipore filtered.
Preparation of Whitten's Medium Ingredient Quantity l0 NaCl 514.0 mg KCl 36.0 mg KH2PO4 l6.0 mg MgSO2(7H2O) 29.0 mg NaHCO 190.0 mg 15 Na Pyruvate 3.5 mg Ca Lactate (5H2O)53.0 mg Glucose 100.0 mg K Penicillin 8.0 mg StreptomycinS04 5.0 mg The medium was made up by adding the listed ingredients to a l00 ml volumetric flask. Next, 0.37 ml of 60% Na Lactate syrup (Sigma Chemical Co.) and 0.1 ml of 1% phenol red were added. The final volume was adjusted to 100 ml with deionized distilled water. The medium then was Millipore filtered (0.22 ~ pore size) and stored at 4C. On the day of use, the medium was supplemented with Bovine Serum Albumin (BSA) (Sigma Chemical Co.) by adding 1.5 mg BSA per ml medium.
EXAMPLE I
Mouse embryos were used in this Example to verify the specificity of the stain for genetic material in living 1~717~
one-cell embryos because the pronuclei of this species are visible in the unstained state. The embryos were obtained from mature female mice which had bred the previous night. The animals were sacrificed by cervical dislocation and the ovaries and oviduct excised. The oviduct was dissected free and one-cell embryos recovered by locating them in the oviduct as a bulging area and puncturing the oviduct wall with fine needles and fine scissors. The cumulus cells were removed by adding 100-200 ~1 hyaluronidase solution (10 mg/ml DPBS) to the area of the dissected oviduct and allowing it to sit for 10 minutes. The one-cell embryos were recovered by pipe~ting, and were washed three times in a solution of 3 mg Bovine Serum Albumin (BSA)/ml DPBS before adding them to Whittens medium. The BSA was purchased from Sigma Chemical Co.
Individual drops of Whittens medium were placed on a plastic culture dish. The drops were scratched to cause them to adhere to the plate and then were overlaid with oil. The one-cell embryos then were placed in the drops.
The pronuclei were visualized using light microscopy before being stained according to the method of this invention.
The 20 ~g/ml strength stain stock solution of Hoechst No. 33342 was used for this Example. It was desired to give the one-cell embryos dosages of 0, 1 ~1, 2 1ll, 5 ~1 or 10 ~1 of stain stock solution in a ~otal medium-embryo-stain volume of 50 ~1 per drop. It therefore was necessary to place the medium-embryo drops on the slides in sizes to accommodate the desired stain 71~
dosage. That is, 49 ~1 medium-embryo for 1 ~1 stain dosage, 48 ~1 medium-embryo for 2 ~1 stain dosage, etc.
The embryos were stained at 37C, pH 7.2 in 5% C02-in-air.
They were left in the stain while being visualized.
The pronuclei and polar bodies of the one-cell mouse embryos were visualized using Nikon~epi-fluorescence attachment No. TMD-EF for Inverted Microscope DIAP~OT-TMP
(Nikon). This system uses a high pressure mercury lamp.
The UV filters used were by Nikon. This system permits visualization with light and fluorescence simultaneously so that it was possible to positively identify the areas of fluorescence as the pronuclei and polar bodies..
All of the 6~ embryos stained in this manner showed distinct fluorescence of both pronuclei and at least one polar body within 15 minutes of initial exposure to the stain, regardless of dosage. Frequently, only one polar body was evident as the second polar body degenerates with time.
Next, 24 one-cell mouse embryos were stained in the 2G same manner as above, using the low dose only (1 ~1 stain solution with 49 ~1 medium-embryo drop). Twenty-three of the 24 fluoresced within 5 minutes after staining.
_.
EXAMPLE II
The procedures of Example I were repeated using one-cell hamster embryos and a dosage of 10 ~1 stain solution per 50 ~1 total drop volume. The first polar body stained after 15 minutes exposure to the stain. The pronuclei did not fluoresce until 30 minutes exposure. Up * Trademark ~, ~'7~
to 45 minutes exposure was required for complete visualization of the two pronuclei and at least one polar body in each egg. As in Example I, both polar bodies did not always stain.
EXAMPLE III
The procedures of Example I were repeated using matured bovine oocytes, one-cell and 2-cell embryos.
Ovaries were obtained from a slaughterhouse. The oocytes were aspirated from the follicles. The cumulus cells were removed prior to staining with hyaluronidase and pipetting as in Example I.
Some of the recovered oocytes were used for staining, as described below, and some were used for in vitro fertilization. The oocytes were incubated for 24 hours at 39C in TAI,P maturation medium and then incubated with ejaculated bull semen in TALP fertilization medium.
One-cell fertilized egg cells were recovered after the 24 hour incubation, washed in DPBS-gentamycin solution and resuspended in fresh TALP fertilization medium. Two-cell embryos were prepared in the same manner, with recovery after 48 hours incubation with sperm and fertilization medium, and then washed and resuspended in fresh fertilization medium.
Stain stock solution with a concentration of 20 ~g Hoechst No. 33342 per ml DPBS was used for this Example.
The procedures of Example I were used with stain dosages of 2 ~ll and 5 ~1 stain per 50 ~1 total volume of medium-embryo-stain. The stain-culture mixtures were incubated at 39C, mounted on glass slides under cover slips, and visualized under ambient conditions.
~ 7~t7~
Polar bodies were visible within 30 minutes after the stain was added. ~he pronuclei of the oocytes and one-cell embryos and the nuclei of the two-cell embryos were visible after one to two hours or more.
The stained cells then were mounted, fixed and cleared to provide a cross-check on the chromatin prese~t. The slides with the stained embryos and oocytes were placed in coplin jars containing approximately 40 ml of acetic acid:ethanol (l:3 (vol/vol3) and allowed to clear overnight at room temperature. Chromatin was stained with 1% aceto-orcein (wt/vol) (1% orcein stain in 60:40 water-acetic acid solution). The chromatin was visualized by light microscopy using Nemarsky and phase optics.
It was found that approximately 15~ of oocytes and early one-cell embryos contained metaphase plates or pronuclei although they had failed to fluoresce upon exposure to the bis-benzimidazole stain. With the two-cell embryos, no instances were seen in which the nucleus failed to fluoresce. The stain did not give any false positives; all embryos which fluoresced were found to contain chromatin when evaluated by the second method.
The chromatin was present in one of the following forms:
(l) scattered or metaphase plate for oocytes (including germinal vesicles for the immature oocytes), (2) pronuclei for fertilized egg cells, (3) nuclei for embryo cells, or (4) condensed sperm heads which penetrated the oocyte but did not undergo normal decondensation to for~ the male pronucleus.
7~
EXA~PLE IV
The basic procedures of Example III were repeated using porcine oocytes, one-cell fertilized eggs and two-cell and four-cell embryos. The oocytes were recovered from bred sows by surgical flushing of the oviducts and suspended in TALP maturation medium. The 60 g/ml strength stain stock solution of Hoechst No. 33342 was used according to the procedures of Example I with stain dosages of 0, 1 ul, 5 ~1 and 10 ~1 per 50 ~1 total volume of medium-embryo-stain. These mixtures were incubated at 39C for 3 hours.
The metaphase plates and polar bodies of oocytes which had not been fertilized and fertilized eggs stained very distinctly, with pronuclei appearing less distinct. In addition, sperm heads which had penetrated the zona of oocytes showed fluorescence. The nuclei of two-cell and four-cell embryos showed very distinct fluorescence. It was found that the 10 ~1 dosage resulted in high levels of background staining.
The stained cells were mounted, fixed and cleared as in Example III, except that they were cleared in acetic acid:ethanol for 48 hours. The results were similar to those in Example III. About 40% of the oocytes and one-cell embryos had failed to fluoresce, although no false positives were observed. The multi-cell embryos were routinely stained with the Hoechst stain.
~7~
EXAMPLE V
The in vitro development of embryos exposed to Hoechst fluorescent stain No. 33342 was evaluated with mouse embryos at the two-cell and morula stages. The embryos were obtained and prepared by the method described in Example I. They were stained with 10 ~1 doses of stain solution (20 ~g/ml concentration, resulting in a dosage of 0.2 ~g per 50 ~1 total drop volume.
The embryos were exposed to the stain for 15 minutes.
Next, the embryos were washed three times in DPBS-gentamycin and cultured in Whitten's medium.
Of 26 two-cell mouse embryos exposed to the stain, 16 or 65% developed to the morula stage. This compares with 21 of 2~ controls (80%) exposed to no stain, i.e., incubated for 15 minutes with 10 ~1 doses of DPBS alone.
When morula-stage embryos were exposed to the stain, 23 of 44 (51%) developed to blastocysts. Of the controls (DPBS only), 23 of 31 (74~) developed to blastocysts.
Example VI
The basic procedures of Example I were repeated, using Hoechst No. 33258 (10 ~g/ml and 20 ~g/ml stain stock solutions) to stain one-cell mouse embryos. The dosages were 0, 5 ~1, and 10 ~1 in 50 ~1 total medium-embryo-stain volume. The embryos were stained under ambient conditions for one-half hour before being examined. The pronuclei and polar bodies fluoresced and were positively identiEied using light microscopy as in Example I. It was found that the 10 ~1 dosage of this stain did not routinely cause overstaining or background staining.
71Çi Example VII
Bovine spermatozoa were stained with Hoechst stain No.
33342 in order to assess sperm motility and tracking patterns. Freshly ejaculated bull semen was washed with DPBS and centrifuged~ The resulting pellet was suspended in TALP medium and exposed to 20 ~g/ml concentration Hoechst No. 33342 stain stock solution at a dosage of 3 ~l/50 ~l. The medium-sperm-stain mixture was incubated for 15 minutes at 39C and observed.
Following staining, the fluorescing sperm were visualized using the Nikon fluorescence system described in Example I. A camera in the microscope's optical system was used to take color time lapse photographs at exposures of from about lO to 20 seconds. The tracks produced by the fluorescent DNA on the developed photographs were analyzed as to rate and pattern of sperm motility. The procedure was repeated with the addition of cumulus-oocyte complexes to the medium, and the resulting photograph was analyzed as to the effect of these cells on sperm motility rate and pattern.
Example VIII
This example was conducted to observe cleavage in porcine embryos of various stages. Embryos were obtained from the reproductive tracts of superovulated sows 48-120 hours after the onset of estrus. The reproductive tracts were recovered after slaughter and were ~lushed in the laboratory to remove the embryos. Embryos recovered ranged from one-cell (48 hours) to multicell morula (120 hour) embryos. Following two washings in a DPBS-BSA
l7~
solution, the e~bryos were either cultured in Whitten's medium (control) or stained and then cultured in Whitten's medium.
The 60 ~g~ml strength stain stock solution of ~oechst No. 33342 was used for this Example. The embryos were incubated for one hour at 39C in either 1, 5 or 10 ~1 stain solution per 50 ~1. This was followed by three 30-minute washings in clean DPBS (1.5 mg/BSA/ml). The washed embryos were cultured for 24 hours in Whitten's medium (1.5 mg/BSA/ml) and then were evaluated for development ~completing cleavage division). The results are shown in Table 1.
Table 1 Stage Dose_ Control 1 ~1 5 ~1 10 ~1 1 or 2 Cell 6/12(50%) -- 2/14(14%) 1/12(8.3%) 4 Cell 28/36(77%)17/27(62%) 14/37(37%) --Multicell 15/16(94%) -- 13/23(56%) --The principles, preferred embodiments and modes of operation of the present invention have been described in the foregoing specification. The invention which is intended to be protected herein, however, is not to be construed as limited to the particular forms disclosed, since these are to be regarded as illustrative rather than restrictive. Variations and changes may be made by those skilled in the art without departing from the spirit of the invention.
Preparation of Whitten's Medium Ingredient Quantity l0 NaCl 514.0 mg KCl 36.0 mg KH2PO4 l6.0 mg MgSO2(7H2O) 29.0 mg NaHCO 190.0 mg 15 Na Pyruvate 3.5 mg Ca Lactate (5H2O)53.0 mg Glucose 100.0 mg K Penicillin 8.0 mg StreptomycinS04 5.0 mg The medium was made up by adding the listed ingredients to a l00 ml volumetric flask. Next, 0.37 ml of 60% Na Lactate syrup (Sigma Chemical Co.) and 0.1 ml of 1% phenol red were added. The final volume was adjusted to 100 ml with deionized distilled water. The medium then was Millipore filtered (0.22 ~ pore size) and stored at 4C. On the day of use, the medium was supplemented with Bovine Serum Albumin (BSA) (Sigma Chemical Co.) by adding 1.5 mg BSA per ml medium.
EXAMPLE I
Mouse embryos were used in this Example to verify the specificity of the stain for genetic material in living 1~717~
one-cell embryos because the pronuclei of this species are visible in the unstained state. The embryos were obtained from mature female mice which had bred the previous night. The animals were sacrificed by cervical dislocation and the ovaries and oviduct excised. The oviduct was dissected free and one-cell embryos recovered by locating them in the oviduct as a bulging area and puncturing the oviduct wall with fine needles and fine scissors. The cumulus cells were removed by adding 100-200 ~1 hyaluronidase solution (10 mg/ml DPBS) to the area of the dissected oviduct and allowing it to sit for 10 minutes. The one-cell embryos were recovered by pipe~ting, and were washed three times in a solution of 3 mg Bovine Serum Albumin (BSA)/ml DPBS before adding them to Whittens medium. The BSA was purchased from Sigma Chemical Co.
Individual drops of Whittens medium were placed on a plastic culture dish. The drops were scratched to cause them to adhere to the plate and then were overlaid with oil. The one-cell embryos then were placed in the drops.
The pronuclei were visualized using light microscopy before being stained according to the method of this invention.
The 20 ~g/ml strength stain stock solution of Hoechst No. 33342 was used for this Example. It was desired to give the one-cell embryos dosages of 0, 1 ~1, 2 1ll, 5 ~1 or 10 ~1 of stain stock solution in a ~otal medium-embryo-stain volume of 50 ~1 per drop. It therefore was necessary to place the medium-embryo drops on the slides in sizes to accommodate the desired stain 71~
dosage. That is, 49 ~1 medium-embryo for 1 ~1 stain dosage, 48 ~1 medium-embryo for 2 ~1 stain dosage, etc.
The embryos were stained at 37C, pH 7.2 in 5% C02-in-air.
They were left in the stain while being visualized.
The pronuclei and polar bodies of the one-cell mouse embryos were visualized using Nikon~epi-fluorescence attachment No. TMD-EF for Inverted Microscope DIAP~OT-TMP
(Nikon). This system uses a high pressure mercury lamp.
The UV filters used were by Nikon. This system permits visualization with light and fluorescence simultaneously so that it was possible to positively identify the areas of fluorescence as the pronuclei and polar bodies..
All of the 6~ embryos stained in this manner showed distinct fluorescence of both pronuclei and at least one polar body within 15 minutes of initial exposure to the stain, regardless of dosage. Frequently, only one polar body was evident as the second polar body degenerates with time.
Next, 24 one-cell mouse embryos were stained in the 2G same manner as above, using the low dose only (1 ~1 stain solution with 49 ~1 medium-embryo drop). Twenty-three of the 24 fluoresced within 5 minutes after staining.
_.
EXAMPLE II
The procedures of Example I were repeated using one-cell hamster embryos and a dosage of 10 ~1 stain solution per 50 ~1 total drop volume. The first polar body stained after 15 minutes exposure to the stain. The pronuclei did not fluoresce until 30 minutes exposure. Up * Trademark ~, ~'7~
to 45 minutes exposure was required for complete visualization of the two pronuclei and at least one polar body in each egg. As in Example I, both polar bodies did not always stain.
EXAMPLE III
The procedures of Example I were repeated using matured bovine oocytes, one-cell and 2-cell embryos.
Ovaries were obtained from a slaughterhouse. The oocytes were aspirated from the follicles. The cumulus cells were removed prior to staining with hyaluronidase and pipetting as in Example I.
Some of the recovered oocytes were used for staining, as described below, and some were used for in vitro fertilization. The oocytes were incubated for 24 hours at 39C in TAI,P maturation medium and then incubated with ejaculated bull semen in TALP fertilization medium.
One-cell fertilized egg cells were recovered after the 24 hour incubation, washed in DPBS-gentamycin solution and resuspended in fresh TALP fertilization medium. Two-cell embryos were prepared in the same manner, with recovery after 48 hours incubation with sperm and fertilization medium, and then washed and resuspended in fresh fertilization medium.
Stain stock solution with a concentration of 20 ~g Hoechst No. 33342 per ml DPBS was used for this Example.
The procedures of Example I were used with stain dosages of 2 ~ll and 5 ~1 stain per 50 ~1 total volume of medium-embryo-stain. The stain-culture mixtures were incubated at 39C, mounted on glass slides under cover slips, and visualized under ambient conditions.
~ 7~t7~
Polar bodies were visible within 30 minutes after the stain was added. ~he pronuclei of the oocytes and one-cell embryos and the nuclei of the two-cell embryos were visible after one to two hours or more.
The stained cells then were mounted, fixed and cleared to provide a cross-check on the chromatin prese~t. The slides with the stained embryos and oocytes were placed in coplin jars containing approximately 40 ml of acetic acid:ethanol (l:3 (vol/vol3) and allowed to clear overnight at room temperature. Chromatin was stained with 1% aceto-orcein (wt/vol) (1% orcein stain in 60:40 water-acetic acid solution). The chromatin was visualized by light microscopy using Nemarsky and phase optics.
It was found that approximately 15~ of oocytes and early one-cell embryos contained metaphase plates or pronuclei although they had failed to fluoresce upon exposure to the bis-benzimidazole stain. With the two-cell embryos, no instances were seen in which the nucleus failed to fluoresce. The stain did not give any false positives; all embryos which fluoresced were found to contain chromatin when evaluated by the second method.
The chromatin was present in one of the following forms:
(l) scattered or metaphase plate for oocytes (including germinal vesicles for the immature oocytes), (2) pronuclei for fertilized egg cells, (3) nuclei for embryo cells, or (4) condensed sperm heads which penetrated the oocyte but did not undergo normal decondensation to for~ the male pronucleus.
7~
EXA~PLE IV
The basic procedures of Example III were repeated using porcine oocytes, one-cell fertilized eggs and two-cell and four-cell embryos. The oocytes were recovered from bred sows by surgical flushing of the oviducts and suspended in TALP maturation medium. The 60 g/ml strength stain stock solution of Hoechst No. 33342 was used according to the procedures of Example I with stain dosages of 0, 1 ul, 5 ~1 and 10 ~1 per 50 ~1 total volume of medium-embryo-stain. These mixtures were incubated at 39C for 3 hours.
The metaphase plates and polar bodies of oocytes which had not been fertilized and fertilized eggs stained very distinctly, with pronuclei appearing less distinct. In addition, sperm heads which had penetrated the zona of oocytes showed fluorescence. The nuclei of two-cell and four-cell embryos showed very distinct fluorescence. It was found that the 10 ~1 dosage resulted in high levels of background staining.
The stained cells were mounted, fixed and cleared as in Example III, except that they were cleared in acetic acid:ethanol for 48 hours. The results were similar to those in Example III. About 40% of the oocytes and one-cell embryos had failed to fluoresce, although no false positives were observed. The multi-cell embryos were routinely stained with the Hoechst stain.
~7~
EXAMPLE V
The in vitro development of embryos exposed to Hoechst fluorescent stain No. 33342 was evaluated with mouse embryos at the two-cell and morula stages. The embryos were obtained and prepared by the method described in Example I. They were stained with 10 ~1 doses of stain solution (20 ~g/ml concentration, resulting in a dosage of 0.2 ~g per 50 ~1 total drop volume.
The embryos were exposed to the stain for 15 minutes.
Next, the embryos were washed three times in DPBS-gentamycin and cultured in Whitten's medium.
Of 26 two-cell mouse embryos exposed to the stain, 16 or 65% developed to the morula stage. This compares with 21 of 2~ controls (80%) exposed to no stain, i.e., incubated for 15 minutes with 10 ~1 doses of DPBS alone.
When morula-stage embryos were exposed to the stain, 23 of 44 (51%) developed to blastocysts. Of the controls (DPBS only), 23 of 31 (74~) developed to blastocysts.
Example VI
The basic procedures of Example I were repeated, using Hoechst No. 33258 (10 ~g/ml and 20 ~g/ml stain stock solutions) to stain one-cell mouse embryos. The dosages were 0, 5 ~1, and 10 ~1 in 50 ~1 total medium-embryo-stain volume. The embryos were stained under ambient conditions for one-half hour before being examined. The pronuclei and polar bodies fluoresced and were positively identiEied using light microscopy as in Example I. It was found that the 10 ~1 dosage of this stain did not routinely cause overstaining or background staining.
71Çi Example VII
Bovine spermatozoa were stained with Hoechst stain No.
33342 in order to assess sperm motility and tracking patterns. Freshly ejaculated bull semen was washed with DPBS and centrifuged~ The resulting pellet was suspended in TALP medium and exposed to 20 ~g/ml concentration Hoechst No. 33342 stain stock solution at a dosage of 3 ~l/50 ~l. The medium-sperm-stain mixture was incubated for 15 minutes at 39C and observed.
Following staining, the fluorescing sperm were visualized using the Nikon fluorescence system described in Example I. A camera in the microscope's optical system was used to take color time lapse photographs at exposures of from about lO to 20 seconds. The tracks produced by the fluorescent DNA on the developed photographs were analyzed as to rate and pattern of sperm motility. The procedure was repeated with the addition of cumulus-oocyte complexes to the medium, and the resulting photograph was analyzed as to the effect of these cells on sperm motility rate and pattern.
Example VIII
This example was conducted to observe cleavage in porcine embryos of various stages. Embryos were obtained from the reproductive tracts of superovulated sows 48-120 hours after the onset of estrus. The reproductive tracts were recovered after slaughter and were ~lushed in the laboratory to remove the embryos. Embryos recovered ranged from one-cell (48 hours) to multicell morula (120 hour) embryos. Following two washings in a DPBS-BSA
l7~
solution, the e~bryos were either cultured in Whitten's medium (control) or stained and then cultured in Whitten's medium.
The 60 ~g~ml strength stain stock solution of ~oechst No. 33342 was used for this Example. The embryos were incubated for one hour at 39C in either 1, 5 or 10 ~1 stain solution per 50 ~1. This was followed by three 30-minute washings in clean DPBS (1.5 mg/BSA/ml). The washed embryos were cultured for 24 hours in Whitten's medium (1.5 mg/BSA/ml) and then were evaluated for development ~completing cleavage division). The results are shown in Table 1.
Table 1 Stage Dose_ Control 1 ~1 5 ~1 10 ~1 1 or 2 Cell 6/12(50%) -- 2/14(14%) 1/12(8.3%) 4 Cell 28/36(77%)17/27(62%) 14/37(37%) --Multicell 15/16(94%) -- 13/23(56%) --The principles, preferred embodiments and modes of operation of the present invention have been described in the foregoing specification. The invention which is intended to be protected herein, however, is not to be construed as limited to the particular forms disclosed, since these are to be regarded as illustrative rather than restrictive. Variations and changes may be made by those skilled in the art without departing from the spirit of the invention.
Claims (25)
1. A method of preparing living mammalian cells selected from the group consisting of germ cells, one-cell fertilized eggs and undifferentiated pre-implantation embryo cells for genetic manipulation by staining the DNA
of said cells, comprising:
(a) contacting said cells with a fluorescent stain selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells and (b) incubating for from up to about 15 minutes to about 3 hours until said DNA fluoresces when exposed to ultraviolet light and at least some of the stained cells remain viable and capable of embryonic development.
of said cells, comprising:
(a) contacting said cells with a fluorescent stain selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells and (b) incubating for from up to about 15 minutes to about 3 hours until said DNA fluoresces when exposed to ultraviolet light and at least some of the stained cells remain viable and capable of embryonic development.
2. The method of Claim 1 in which said cells or eggs are in culture medium.
3. The method of Claim 1 in which said stain is used in solution.
4. A mammalian cell selected from the group consisting of germ cells, one-cell fertilized eggs and undifferentiated pre-implantation embryo cells, the cell having its DNA stained in accordance with the method of Claim 1.
5. The cell of Claim 1 in which the stain is used in solution.
6. The method of Claim 1 in which said living mammalian cells are bovine or porcine one-cell fertilized eggs.
7. A process for removing a nucleus or the male and female pronuclei of the cell from a living mammalian germ cell, one-cell fertilized egg or undifferentiated pre-implantation embryo cell comprising (a) suspending living cells or eggs in a medium, (b) contacting the suspension with a fluorescent dye selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, (c) incubating for from up to about 15 minutes to about 3 hours until the nucleus or male and female pronuclei fluoresce upon illumination with ultraviolet light and a plurality of the stained cells remain viable and capable of embryonic development, and (d) removing said nucleus or male and female pronuclei from said cells using micromanipulation techniques.
8. The process of Claim 7 in which said one-cell fertilized eggs are bovine or porcine one-cell fertilized eggs.
9. The process of Claim 7 in which the fluorescent dye is selected from the group consisting of DAPI, DIPI
and bis-benzimidazole compounds.
and bis-benzimidazole compounds.
10. The process of Claim 9 in which the dye is in solution.
11. Fluorescent mammalian DNA which has been isolated by the process comprising:
(a) contacting the cells of Claim 1 with fluorescent dye according to the process of Claim 1, (b) incubating the cells until the DNA
fluoresces when exposed to ultraviolet light.
(a) contacting the cells of Claim 1 with fluorescent dye according to the process of Claim 1, (b) incubating the cells until the DNA
fluoresces when exposed to ultraviolet light.
12. A process for transferring DNA fragments containing the desired gene sequences into a pronucleus of a living mammalian pronuclear cell comprising:
(a) contacting said cell with a fluorescent dye selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, (b) incubating for from up to about 15 minutes to about 3 hours until the pronuclei fluoresce and a plurality of the stained cells remain viable and capable of embryonic development, and (c) transferring the desired genetic material into a pronucleus of said pronuclear cell by micromanipulation techniques.
(a) contacting said cell with a fluorescent dye selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, (b) incubating for from up to about 15 minutes to about 3 hours until the pronuclei fluoresce and a plurality of the stained cells remain viable and capable of embryonic development, and (c) transferring the desired genetic material into a pronucleus of said pronuclear cell by micromanipulation techniques.
13. The process of Claim 12 in which said pronuclear cells are bovine or porcine one-cell fertilized eggs.
14. The process of Claim 12 in which said cells are in culture medium.
15. The process of Claim 12 in which the dye is in solution.
16. A genetically altered, living unicellular mammalian cell having genetic material inserted into it by the process of Claim 13.
17. The process of Claim 12 in which said pronucleus is isolated by a process comprising:
(a) contacting the cell containing said pronucleus with a fluorescent dye at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, (b) incubating for from up to about 15 minutes to about 3 hours until said pronucleus fluoresces and the pronucleus of a plurality of the cells so contacted remains functional, and (c) removing said pronucleus from the cell by micromanipulation techniques.
(a) contacting the cell containing said pronucleus with a fluorescent dye at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, (b) incubating for from up to about 15 minutes to about 3 hours until said pronucleus fluoresces and the pronucleus of a plurality of the cells so contacted remains functional, and (c) removing said pronucleus from the cell by micromanipulation techniques.
18. The process of Claim 17 in which the dye is in solution.
19. Fluorescent mammalian DNA in living mammalian cells selected from the group consisting of germ cells, one-cell fertilized eggs and undifferentiated pre-implantation embryo cells, produced by a process comprising:
(a) contacting the cells with a fluorescent dye selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, and (b) incubating for from up to about 15 minutes to about 3 hours until the DNA fluoresces when exposed to ultraviolet light and the DNA of a plurality of the cells so stained remains functional.
(a) contacting the cells with a fluorescent dye selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, and (b) incubating for from up to about 15 minutes to about 3 hours until the DNA fluoresces when exposed to ultraviolet light and the DNA of a plurality of the cells so stained remains functional.
20. The fluorescent mammalian DNA of Claim 19 in which the living mammalian cells used to prepare said fluorescent DNA are bovine or porcine one-cell fertilized eggs and said fluorescent DNA comprises the pronuclei of the cells.
21. The fluorescent mammalian DNA of Claim 19 in which said stain is used in solution.
22. A method for preparing sperm cells for the assessment of spermatozoan motility and tracking pattern comprising:
(a) contacting sperm cells with a fluorescent stain selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, and (b) incubating for from up to about 15 minutes to about 3 hours until DNA in the sperm heads fluoresces when exposed to ultraviolet light and a plurality of said sperm cells remain viable and active.
(a) contacting sperm cells with a fluorescent stain selected from the group consisting of DAPI (4',6'-diamidino-2-phenylindole) and bis-benzimidazole compounds at a stain dosage of from about .001 µg to about 10 µg per 50 µ1 culture containing said cells, and (b) incubating for from up to about 15 minutes to about 3 hours until DNA in the sperm heads fluoresces when exposed to ultraviolet light and a plurality of said sperm cells remain viable and active.
23. The method of Claim 22 in which said fluorescent stain is selected from the group consisting of DAPI, DIPI and bis-benzimidazole compounds.
24. The method of Claim 23 in which said stain is in solution.
25. A method for the comparative assessment of spermatozoan motility and tracking pattern comprising studying a photographic representation made by preparing sperm cells according to the method of Claim 22 and preparing a time exposure photograph of the fluorescing sperm in order to determine the qualitive or quantitive aspects of said tracking pattern.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52062983A | 1983-08-05 | 1983-08-05 | |
US520,629 | 1983-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1271716A true CA1271716A (en) | 1990-07-17 |
Family
ID=24073420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000458836A Expired CA1271716A (en) | 1983-08-05 | 1984-07-13 | Technique for visualization of genetic material |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPH07104341B2 (en) |
AU (1) | AU581409B2 (en) |
CA (1) | CA1271716A (en) |
CH (1) | CH669670A5 (en) |
DE (1) | DE3427553C2 (en) |
FR (1) | FR2550218B1 (en) |
GB (1) | GB2144542B (en) |
MX (1) | MX161889A (en) |
NL (1) | NL8401137A (en) |
NZ (1) | NZ207393A (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3636991A1 (en) * | 1986-03-03 | 1987-09-24 | Transgene Gmbh | METHOD FOR TRANSMITTING ORGANIC AND / OR INORGANIC SUBSTANCES ON EGGS AND / OR SOMA CELLS OF ANIMALS AND CORRESPONDING COMPOSITIONS |
GB2214518A (en) * | 1988-01-28 | 1989-09-06 | Innofinance Altalanos Innovaci | Process and equipment for the rapid determination of the spermium cell count and/or living spermium count |
NZ239893A (en) * | 1990-09-25 | 1993-11-25 | Hoechst Japan | A method for introducing a foreign dna into a cell |
CA2279574C (en) | 1997-01-31 | 2007-07-24 | The Horticulture & Food Research Institute Of New Zealand Ltd. | Optical apparatus |
US6149867A (en) | 1997-12-31 | 2000-11-21 | Xy, Inc. | Sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
DE19829495A1 (en) * | 1998-07-02 | 2000-01-05 | Jacques Paysan | Reagents and their application for the investigation of interactions between cellular molecules and their localization in cells |
FR2800736B1 (en) * | 1999-11-05 | 2002-08-23 | Aventis Pharma Sa | DERIVATIVES OF OLIGOBENZIMIDAZOLES, COMPOSITIONS CONTAINING THEM AND USES THEREOF |
ES2211644T3 (en) * | 1999-11-05 | 2004-07-16 | Aventis Pharma S.A. | DERIVATIVES OF OLIGO BENCIMIDAZOLES AND ITS USE AS AGENTS OF TRANSFECTION OF DNA. |
US7208265B1 (en) | 1999-11-24 | 2007-04-24 | Xy, Inc. | Method of cryopreserving selected sperm cells |
CA2468772C (en) | 2000-11-29 | 2013-10-29 | George E. Seidel | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
US7713687B2 (en) | 2000-11-29 | 2010-05-11 | Xy, Inc. | System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
US8486618B2 (en) | 2002-08-01 | 2013-07-16 | Xy, Llc | Heterogeneous inseminate system |
EP1545203B1 (en) | 2002-08-01 | 2016-10-19 | Xy, Llc | Low pressure sperm cell separation system |
AU2003265471B2 (en) | 2002-08-15 | 2009-08-06 | Xy, Llc. | High resolution flow cytometer |
US7169548B2 (en) | 2002-09-13 | 2007-01-30 | Xy, Inc. | Sperm cell processing and preservation systems |
DE10305768A1 (en) * | 2003-02-11 | 2004-08-19 | Justus-Liebig-Universität Giessen | Selective staining of lipophilic cells or components, useful particularly in diagnostic determination of eosinophils, uses an extract containing physcion and fluorescent microscopy |
DK2305171T3 (en) | 2003-03-28 | 2022-03-21 | Inguran Llc | Apparatus and methods for providing sexed animal semen |
DK1625203T3 (en) | 2003-05-15 | 2015-07-06 | Xy Llc | EFFECTIVE SEPARATION OF haploid cells FOR FLOWCYTOMETRISYSTEMER |
BRPI0509485A (en) | 2004-03-29 | 2007-09-11 | Monsanto Technology Llc | sperm suspensions for use in insemination |
MX2007000888A (en) | 2004-07-22 | 2007-04-02 | Monsanto Technology Llc | Process for enriching a population of sperm cells. |
CN102944456A (en) * | 2012-11-07 | 2013-02-27 | 西北农林科技大学 | Preparation method and application of tissue slice for observing temporal-spatial distribution of early embryo development in vivo |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4094745A (en) * | 1973-06-22 | 1978-06-13 | John Scholefield | Method of staining microscopic organisms |
US3872312A (en) * | 1973-07-02 | 1975-03-18 | Block Engineering | Method and apparatus for detecting and classifying nucleic acid particles |
JPS5262080A (en) * | 1975-11-15 | 1977-05-23 | Particle Tech Inc | Method of and apparatus for classifying organism cell |
DE2651060C3 (en) * | 1976-11-09 | 1980-06-26 | Boehringer Mannheim Gmbh, 6800 Mannheim | Differential diagnostic semen examination |
CA1155041A (en) * | 1980-04-21 | 1983-10-11 | Michael E. Jolley | Fluorescent nucleic acid stains |
CA1197186A (en) * | 1982-03-19 | 1985-11-26 | Robert A. Hoffman | Method of enumerating serologically selected cell populations |
-
1984
- 1984-03-06 NZ NZ207393A patent/NZ207393A/en unknown
- 1984-04-10 NL NL8401137A patent/NL8401137A/en not_active Application Discontinuation
- 1984-07-13 CA CA000458836A patent/CA1271716A/en not_active Expired
- 1984-07-23 JP JP59151469A patent/JPH07104341B2/en not_active Expired - Lifetime
- 1984-07-25 AU AU31159/84A patent/AU581409B2/en not_active Ceased
- 1984-07-26 DE DE3427553A patent/DE3427553C2/en not_active Expired - Fee Related
- 1984-07-27 GB GB08419143A patent/GB2144542B/en not_active Expired
- 1984-08-02 MX MX202236A patent/MX161889A/en unknown
- 1984-08-03 FR FR8412355A patent/FR2550218B1/en not_active Expired
- 1984-08-03 CH CH3760/84A patent/CH669670A5/de not_active IP Right Cessation
-
1994
- 1994-02-28 JP JP6052567A patent/JPH0751059A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU3115984A (en) | 1985-02-07 |
GB2144542B (en) | 1987-05-07 |
NZ207393A (en) | 1987-03-31 |
FR2550218B1 (en) | 1989-01-20 |
JPH0751059A (en) | 1995-02-28 |
MX161889A (en) | 1991-02-26 |
NL8401137A (en) | 1985-03-01 |
JPH07104341B2 (en) | 1995-11-13 |
GB2144542A (en) | 1985-03-06 |
CH669670A5 (en) | 1989-03-31 |
JPS6044869A (en) | 1985-03-11 |
AU581409B2 (en) | 1989-02-23 |
FR2550218A1 (en) | 1985-02-08 |
DE3427553C2 (en) | 1994-04-14 |
GB8419143D0 (en) | 1984-08-30 |
DE3427553A1 (en) | 1985-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1271716A (en) | Technique for visualization of genetic material | |
Maxwell et al. | The relationship between membrane status and fertility of boar spermatozoa after flow cytometric sorting in the presence or absence of seminal plasma | |
Wall et al. | Development of porcine ova that were centrifuged to permit visualization of pronuclei and nuclei | |
Westhusin et al. | Viable embryos and normal calves after nuclear transfer into Hoechst stained enucleated demi-oocytes of cows | |
Kishikawa et al. | Fertility of mouse spermatozoa retrieved from cadavers and maintained at 4 C | |
Van Soom et al. | Compaction rate of in vitro fertilized bovine embryos related to the interval from insemination to first cleavage | |
Yoshida et al. | Confocal and fluorescence microscopic study using lectins of the distribution of cortical granules during the maturation and fertilization of pig oocytes | |
Zhang et al. | In vitro fertilization of horse follicular oocytes matured in vitro | |
Jewgenow et al. | Viability of small preantral ovarian follicles from domestic cats after cryoprotectant exposure and cryopreservation | |
Conover et al. | Pre-loading of mouse oocytes with DNA-specific fluorochrome (Hoechst 33342) permits rapid detection of sperm–oocyte fusion | |
Luttmer et al. | Examination of living and fixed gametes and early embryos stained with supravital fluorochromes (Hoechst 33342 and 3, 3′‐dihexyloxacarbocyanine iodide) | |
Critser et al. | Use of a fluorescent stain for visualization of nuclear material in living oocytes and early embryos | |
Saraf et al. | Sperm functional attributes and oviduct explant binding capacity differs between bulls with different fertility ratings in the water buffalo (Bubalus bubalis) | |
EP1255812A1 (en) | Process for the production of non-human embryos of high-genetic value and of predetermined sex | |
US5858354A (en) | Repopulation of testicular Seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny | |
Block et al. | Inheritance of resistance of bovine preimplantation embryos to heat shock: relative importance of the maternal versus paternal contribution | |
Yanagimachi | Fertilization studies and assisted fertilization in mammals: their development and future | |
刀禰重信 et al. | A method of vital staining of mouse eggs using Hoechst dye. | |
Mori et al. | Fluorescence microscopy of nuclear DNA in oocytes and zygotes during in vitro fertilization and development of early embryos in mice | |
Velilla et al. | Effect of Hoechst 33342 staining on developmental competence of prepubertal goat oocytes | |
Minhas et al. | Visualization of pronuclei in living bovine zygotes | |
Xu et al. | Pregnancy rates following transfer of bovine embryos produced by in vitro maturation, fertilization and co-culture | |
Nakanishi et al. | Early nuclear events of in vitro fertilization in the domestic fowl (Gallus domesticus) | |
Polge | How does embryo manipulation fit into present and future pig reproduction | |
Saadi et al. | Modern reproductive technologies and breed improvement. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |